Axsome Begins Phase III Study on AXS-05 for Smoking Cessation
AXSM begins dosing in the phase III SUMMIT study investigating AXS-05 for treating smoking cessation in adults.
AXS - AXIS Capital Holdings Limited
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$121.50
DETAILS
HIGH:
$130.00
LOW:
$108.00
MEDIAN:
$124.00
CONSENSUS:
$121.50
UPSIDE:
20.51%
Stock News
Axsome Therapeutics Initiates SUMMIT Phase 3 Trial of AXS-05 in Smoking Cessation
NEW YORK, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that the first patient has been dosed in the SUMMIT Phase 3 trial of AXS-05 for smoking cessation. SUMMIT (Studying NMDA and Sigma-1 in Smoking Cessation Treatment) is a Phase 3 randomized, double-blind, active- and placebo-controlled, multicenter trial to assess the efficacy and safety of AXS-05 as a smoking cessation treatment in adults.
Why Is Axis Capital (AXS) Down 5.6% Since Last Earnings Report?
Axis Capital (AXS) reported earnings 30 days ago. What's next for the stock?
Axis Capital's Insurance Operations Power Diversified Growth
AXS' Insurance segment drives premium growth through specialty underwriting, product diversification and disciplined risk selection.
AXS PFD E Offers Competitive Yield Versus Other Insurance Companies
AXIS Capital Holdings Limited offers diversified specialty insurance and reinsurance, with strong A+ credit ratings and a BBB-rated preferred stock AXS.PR.E. AXS reported 15% YOY growth in both premiums written and diluted book value, with a solid 93.1% combined ratio, though reinsurance premiums declined 25%. The fixed-rate, non-cumulative Series E preferred AXS.PR.E offers QDI-eligible dividends and BBB credit quality, appealing for income-focused investors seeking stability.
Bank of America Corp DE Reduces Stock Position in Axis Capital Holdings Limited $AXS
Bank of America Corp DE lessened its stake in Axis Capital Holdings Limited (NYSE: AXS) by 7.1% in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 473,337 shares of the insurance provider's stock after selling 35,912 shares during the quarter. Bank
AXS Lags Industry, Trades at a Discount: Here's How to Play the Stock
AXIS Capital's specialty focus, premium growth and capital returns support growth, while catastrophe losses and competition pressure on underwriting margins.
AXIS Agrees to Acquire Renewal Rights to DUAL North America's Excess Liability Business
Acquisition Strengthens AXIS' Casualty Platform with High-Performing Book, Ensuring Continuity for Brokers and Policyholders Acquisition Strengthens AXIS' Casualty Platform with High-Performing Book, Ensuring Continuity for Brokers and Policyholders
AXS Named Exclusive Primary and Secondary Ticketing Partner for the Wrangler National Finals Rodeo
LOS ANGELES & LAS VEGAS--(BUSINESS WIRE)--AXS Named Exclusive Primary and Secondary Ticketing Partner for the Wrangler National Finals Rodeo.
California State Teachers Retirement System Grows Holdings in Axis Capital Holdings Limited $AXS
California State Teachers Retirement System grew its position in shares of Axis Capital Holdings Limited (NYSE: AXS) by 25.7% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 92,474 shares of the insurance provider's stock after purchasing an additional 18,934 shares during
AXIS Appoints Rahil Jogani as Head of Technology & Artificial Intelligence Strategy
PEMBROKE, Bermuda, July 29, 2026 (GLOBE NEWSWIRE) -- AXIS Capital Holdings Limited (“AXIS Capital,” “AXIS” or the “Company”) (NYSE: AXS) today announced that it has hired Rahil Jogani to the newly created role of Head of Technology & Artificial Intelligence (AI) Strategy. He will be based in the New York office and report to Group Chief Operations Officer Ann Haugh.
Axis Capital Q2 Earnings Call Highlights
Axis Capital NYSE: AXS reported second-quarter results marked by higher insurance premiums, continued profitability in its reinsurance business and an increased focus on underwriting discipline as specialty insurance market conditions soften.
AXIS Capital Holdings Limited (AXS) Q2 2026 Earnings Call Transcript
AXIS Capital Holdings Limited (AXS) Q2 2026 Earnings Call Transcript
AXIS Capital Q2 Earnings Miss Estimates on Higher Catastrophe Losses
AXS's Q2 results reflect premium growth, but higher catastrophe losses and weaker investment income weigh on earnings.
Here's What Key Metrics Tell Us About Axis Capital (AXS) Q2 Earnings
The headline numbers for Axis Capital (AXS) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Axis Capital (AXS) Misses Q2 Earnings and Revenue Estimates
Axis Capital (AXS) came out with quarterly earnings of $2.84 per share, missing the Zacks Consensus Estimate of $3.23 per share. This compares to earnings of $3.29 per share a year ago.
AXIS Capital Reports Second Quarter Net Income Available to Common Shareholders of $251 Million, or $3.38 Per Diluted Common Share and Operating Income of $211 Million, or $2.84 Per Diluted Common Share
For the second quarter of 2026 , the Company reports: Annualized return on average common equity ("ROACE") of 17.0% and annualized operating ROACE of 14.3% Combined ratio of 93.1% , producing underwriting income of $143 million Book value per diluted common share of $80.67 For the six months ended June 30, 2026 , the Company reports: Net income available to common shareholders of $498 million , or $ 6.67 per diluted common share and operating income of $468 million , or $ 6.26 per diluted common share Annualized return on average common equity ("ROACE") of 16.9% and annualized operating ROACE of 15.9% Combined ratio of 91.5% , producing underwriting income of $330 million Book value per diluted common share of $80.67 , an increase of $3.47 , or 4.5% , compared to December 31, 2025 , and an increase of $10.33 , or 14.7% compared to June 30, 2025 PEMBROKE, Bermuda, July 28, 2026 (GLOBE NEWSWIRE) -- AXIS Capital Holdings Limited ("AXIS Capital" or "AXIS" or "the Company") (NYSE: AXS) today announced financial results for the second quarter ended June 30, 2026. Commenting on the second quarter 2026 financial results, Vince Tizzio, President and CEO of AXIS Capital said: "AXIS continued to generate consistent, profitable growth in the second quarter, amidst an evolving risk landscape impacted by the Middle East conflict and further transitioning market conditions.
Bank of Nova Scotia Purchases 72,465 Shares of Axis Capital Holdings Limited $AXS
Bank of Nova Scotia increased its position in Axis Capital Holdings Limited (NYSE: AXS) by 65.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 183,169 shares of the insurance provider's stock after purchasing an additional 72,465 shares during the
Axis Capital (AXS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Axis Capital (AXS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Axis Capital (AXS) Beat Estimates Again in Its Next Earnings Report?
Axis Capital (AXS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Price Targets
Axis Capital price target lowered to $126 from $131 at UBS
$126.00
(was $105.32)
Brian Meredith
·
UBS
Axis Capital price target lowered to $130 from $142 at Mizuho
$130.00
(was $105.32)
Mizuho Securities
AXIS Capital (AXS) PT Lowered to $108 at BMO Capital
$108.00
(was $105.89)
Michael Zaremski
·
Capital One Financial
Axis Capital price target raised to $122 from $115 at BofA
$122.00
(was $111.55)
Atlantic Equities
Axis Capital price target raised to $142 from $137 at Mizuho
$142.00
(was $112.85)
Mizuho Securities
Axis Capital price target raised to $131 from $129 at UBS
$131.00
(was $114.00)
Brian Meredith
·
UBS
Axis Capital price target lowered to $137 from $140 at Mizuho
$137.00
(was $100.13)
Mizuho Securities
Axis Capital price target lowered to $140 from $141 at Mizuho
$140.00
(was $99.23)
Mizuho Securities
Axis Capital price target raised to $141 from $133 at Mizuho
$141.00
(was $103.18)
Mizuho Securities
Axis Capital price target raised to $129 from $126 at UBS
$129.00
(was $103.18)
Brian Meredith
·
UBS
Axis Capital price target raised to $130 from $125 at RBC Capital
$130.00
(was $104.11)
UBS
Axis Capital price target raised to $122 from $121 at Jefferies
$122.00
(was $103.51)
Jefferies
Axis Capital price target raised to $120 from $110 at Roth Capital
$120.00
(was $103.92)
Roth Capital
Axis Capital price target raised to $124 from $118 at Wells Fargo
$124.00
(was $101.37)
Wells Fargo
Axis Capital price target raised to $110 from $103 at Goldman Sachs
$110.00
(was $103.23)
Goldman Sachs
Axis Capital initiated with an Outperform at Mizuho
$133.00
(was $106.38)
Mizuho Securities
Axis Capital initiated with an Outperform at RBC Capital
$125.00
(was $99.57)
RBC Capital
Axis Capital price target raised to $121 from $119 at Keefe Bruyette
$121.00
(was $100.89)
Compass Point
Axis Capital initiated with a Neutral at Goldman Sachs
$104.00
(was $97.34)
Goldman Sachs
Axis Capital price target raised to $120 from $119 at UBS
$120.00
(was $96.54)
Brian Meredith
·
UBS